Gaxos.ai Inc. GXAI shares are trading higher Wednesday after the company announced it has acquired the rights to use certain AI-enabled biohacking technology from Ultiself.
The Details:
Gaxos.Ai said it will integrate the technology from Ultiself into its proposed product offering to enable enhanced customization and user experience.
“By securing the rights to use this tech, we will be able to accelerate the development of our AI-enabled application for the Gaxos Health product offering,” said Vadim Mats, CEO of Gaxos.AI.
“This tech is intended to allow us to offer a more customized approach to delivering customers diet, nutrition, and tracking capabilities," Mats added.
Related News: Phunware’s Stock Slips After Q4 EPS Miss – Here’s Why
How To Buy GXAI Stock:
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Gaxos.AI GXAI's case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
GXAI Price Action: According to Benzinga Pro, Gaxos.Ai shares are up 100% at $10.64 at the time of publication.
Image: Steve Buissine from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
